Literature DB >> 19540212

Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

Anitha P Govind1, Paul Vezina, William N Green.   

Abstract

A major hurdle in defining the molecular biology of nicotine addiction has been characterizing the different nicotinic acetylcholine receptor (nAChR) subtypes in the brain and how nicotine alters their function. Mounting evidence suggests that the addictive effects of nicotine, like other drugs of abuse, occur through interactions with its receptors in the mesolimbic dopamine system, particularly ventral tegmental area (VTA) neurons, where nicotinic receptors act to modulate the release of dopamine. The molecular identity of the nicotinic receptors responsible for drug seeking behavior, their cellular and subcellular location and the mechanisms by which these receptors initiate and maintain addiction are poorly defined. In this commentary, we review how nicotinic acetylcholine receptors (nAChRs) are upregulated by nicotine exposure, the potential posttranslational events that appear to cause it and how upregulation is linked to nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540212      PMCID: PMC2728164          DOI: 10.1016/j.bcp.2009.06.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  152 in total

1.  Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors.

Authors:  W Xu; A Orr-Urtreger; F Nigro; S Gelber; C B Sutcliffe; D Armstrong; J W Patrick; L W Role; A L Beaudet; M De Biasi
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites.

Authors:  Y M Ulrich; K M Hargreaves; C M Flores
Journal:  Neuropharmacology       Date:  1997-08       Impact factor: 5.250

3.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

4.  Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.

Authors:  Paul Vezina; Daniel S Lorrain; Gretchen M Arnold; Jennifer D Austin; Nobuyoshi Suto
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

5.  Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific.

Authors:  E M Sanderson; A L Drasdo; K McCrea; S Wonnacott
Journal:  Brain Res       Date:  1993-07-23       Impact factor: 3.252

6.  alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.

Authors:  V Gerzanich; F Wang; A Kuryatov; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

Review 7.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

8.  Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.

Authors:  S R Grady; M J Marks; A C Collins
Journal:  J Neurochem       Date:  1994-04       Impact factor: 5.372

9.  Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.

Authors:  M A Russell; M Jarvis; R Iyer; C Feyerabend
Journal:  Br Med J       Date:  1980-04-05

10.  Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.

Authors:  J Michael McIntosh; Layla Azam; Sarah Staheli; Cheryl Dowell; Jon M Lindstrom; Alexander Kuryatov; James E Garrett; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

View more
  122 in total

1.  Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Authors:  Olivier George; Allison Lloyd; F Ivy Carroll; M Imad Damaj; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

2.  Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei; Mohammad F Ullah; Howard K Plummer
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

3.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 4.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

5.  Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex.

Authors:  Danielle S Counotte; Natalia A Goriounova; Milena Moretti; Marek T Smoluch; Hubertus Irth; Francesco Clementi; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Cecilia Gotti; Sabine Spijker
Journal:  FASEB J       Date:  2012-02-03       Impact factor: 5.191

6.  The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors.

Authors:  Ashley M Fox; Faruk H Moonschi; Christopher I Richards
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

7.  Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.

Authors:  Linda M Lucero; Maegan M Weltzin; J Brek Eaton; John F Cooper; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

8.  Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.

Authors:  Michelle G Baladi; Shannon M Nielsen; J Michael McIntosh; Glen R Hanson; Annette E Fleckenstein
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

Review 9.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

Review 10.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.